Clinical Trial Update: A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bioequivalence of 70-mg alendronate alone and in combination with 5600 IU vitamin D (MK0217A-253) for osteoporosis; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Vitamin D (Cholecalciferol)
• alendronate (alendronate)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2011-05-09